Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-10 Purchase | 2021-11-10 7:31 pm | Calithera Biosciences Inc. | CALA | DRACHMAN JONATHAN G Director | 200,000 | $0.8595 | $171,900 | 200,000 (Direct) | View |
| 2021-08-24 Purchase | 2021-08-26 7:08 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 150,000 | $6.2237 | $933,550 | 2,373,686 (Indirect Direct) | View |
| 2021-06-03 Purchase | 2021-06-07 5:06 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 50,000 | $9.5071 | $475,354 | 2,248,686 (Direct) | View |
| 2019-12-20 Purchase | 2019-12-20 6:53 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 119,047 | $8.4 | $999,995 | 2,198,686 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 5:39 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G See Remarks | 250,000 | $3.127 | $781,747 | 591,856 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-23 4:32 pm | N/A 2033-06-21 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:38 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 6:45 pm | N/A 2032-06-21 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2021-10-26 Ownership | 2022-02-14 7:54 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 75,000 | $0 | 2,298,686 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:12 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | Calithera Biosciences Inc. | CALA | DRACHMAN JONATHAN G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-04 Option Award(A) | 2021-05-14 7:59 pm | N/A 2031-05-03 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2021-05-04 Option Award | 2021-05-07 9:53 pm | N/A 2031-05-03 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2020-08-10 Option Award | 2020-08-12 4:08 pm | N/A 2030-08-10 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 420,000 | $0 | 420,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:01 pm | N/A 2030-06-08 | Calithera Biosciences Inc. | CALA | DRACHMAN JONATHAN G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 9:42 pm | N/A 2030-05-27 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 13,047 | $0 | 13,047 (Direct) | View |
| 2019-11-12 Conversion | 2019-12-20 6:53 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 1,274,216 | $0 | 2,198,686 (Direct) | View |
| 2019-08-08 Option Award(A) | 2019-09-13 7:18 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G See Remarks | 580,655 | $0 | 12,616 (Direct) | View |
| 2019-08-31 Option Award | 2019-09-04 4:48 pm | N/A 2029-08-31 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G See Remarks | 1,650,000 | $0 | 1,650,000 (Direct) | View |
| 2019-08-08 Option Award | 2019-08-12 5:54 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 341,856 | $0 | 7,428 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:20 pm | N/A 2029-06-02 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 4:06 pm | N/A 2029-05-29 | Calithera Biosciences Inc. | CALA | DRACHMAN JONATHAN G Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-03-29 4:17 pm | N/A 2029-02-06 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 4,266 | $0 | 4,266 (Direct) | View |
Ownership | 2019-02-07 6:42 pm | N/A 2028-08-31 | Harpoon Therapeutics Inc. | HARP | DRACHMAN JONATHAN G Director | 0 | $0 | 55,312 (Direct) | View |